tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

composite endpoints

0

Caitlin Rothermel

Posted on March 7, 2013 by Patti Peeples, R.Ph., Ph.D.

What do you think?  Should PROs be included in composite endpoints along with more traditional clinical measures?  Read Cardiovascular Disease and Patient-reported Outcomes – Can Composite Endpoints Work? by Caitlin Rothermel and weigh in!

Guest Bloggers cardiovascular disease, clinical trials, composite endpoints, Evidence-based medicine, PROs

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • Between Two Scientists: Data Linkage – Like Making a Fine, Blended Wine from Varietal Data Sources
  • The Sooner, the Better: Detecting and Decoding Alzheimer’s with Real-World Data
  • Ongoing Medicare Privatization Will Hurt Pharma As Much As the IRA
  • Leveraging Real-World Data for Precision Obesity Treatment

HealthEconomics.Com Twitter Feed

www_healthecon Follow

@ ·
now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes